MedTrace Logo

Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

NCT05226884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2024-11-15

Study results available
· View outcomes & findings →

Summary

Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.

Conditions

  • Pseudophakia

Interventions

DIAGNOSTIC_TEST

Visual Acuity

Measurement of distance and intermediate visual acuity at variety targeted correction.

DIAGNOSTIC_TEST

Defocus Curve

Measurement of a defocus curve

Sponsors & Collaborators

  • Berkeley Eye Center

    lead OTHER

Principal Investigators

  • Morgan Micheletti, MD · Berkeley Eye Center

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-08-06
Completion
2022-08-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05226884 on ClinicalTrials.gov